Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cancer therapeutics and mechanisms, Synthesis and pharmacology of benzodiazepine derivatives, HER2/EGFR in Cancer Research, and Antibiotic Resistance in Bacteria.
Current economic and regulatory challenges in developing antibiotics for Gram-negative bacteria
Understanding the mechanisms of resistance to azole antifungals in <i>Candida</i> species
New Generation Modified Azole Antifungals against Multidrug-Resistant <i>Candida auris</i>
Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation
Evaluation of Antibiotic Resistance Mechanisms in Gram-Positive Bacteria
Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
Evaluation of Antibiotic Resistance Mechanisms in Gram-Negative Bacteria
Antibody–Drug Conjugates—A Tutorial Review
Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance
Schiff bases of sulphonamides as a new class of antifungal agent against multidrug‐resistant <i>Candida auris</i>
Synthesis, microbiological evaluation and structure activity relationship analysis of linezolid analogues with different C5-acylamino substituents
Development of sulfonamide-based Schiff bases targeting urease inhibition: Synthesis, characterization, inhibitory activity assessment, molecular docking and ADME studies
Probing sulphamethazine and sulphamethoxazole based Schiff bases as urease inhibitors; synthesis, characterization, molecular docking and ADME evaluation
Antibiotic resistance breakers: current approaches and future directions
Effectiveness of Efflux Pump Inhibitors as Biofilm Disruptors and Resistance Breakers in Gram-Negative (ESKAPEE) Bacteria
Region-specific blood–brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease
SmvA is an important efflux pump for cationic biocides in Klebsiella pneumoniae and other Enterobacteriaceae
Role of bacterial efflux pumps in biofilm formation
Mapping the Dynamic Functions and Structural Features of AcrB Efflux Pump Transporter Using Accelerated Molecular Dynamics Simulations
Cytotoxic Naphthoquinone and Azaanthraquinone Derivatives from an Endophytic <i>Fusarium solani</i>
Triaryl Benzimidazoles as a New Class of Antibacterial Agents against Resistant Pathogenic Microorganisms
Fluoxetine and thioridazine inhibit efflux and attenuate crystalline biofilm formation by Proteus mirabilis
Computational Study Reveals the Molecular Mechanism of the Interaction between the Efflux Inhibitor PAβN and the AdeB Transporter from <i>Acinetobacter baumannii</i>
Novel pyridyl nitrofuranyl isoxazolines show antibacterial activity against multiple drug resistant Staphylococcus species
From Anthramycin to Pyrrolobenzodiazepine (PBD)‐Containing Antibody–Drug Conjugates (ADCs)
Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux Pumps
Recent Advances in Targeting the Telomeric G-Quadruplex DNA Sequence with Small Molecules as a Strategy for Anticancer Therapies
Topical therapies for skin cancer and actinic keratosis
Crispene E, a cis-clerodane diterpene inhibits STAT3 dimerization in breast cancer cells
Observation of unphosphorylated STAT3 core protein binding to target <i>ds</i>DNA by PEMSA and X‐ray crystallography